[Top Trade ideas] Alzheimer’s Drug Up Over 30%

Good morning trader! Here are our top 3 trade ideas today. These setups look primed! Be the best prepared trader on the Street!  👉[MyMD Pharmaceuticals, Inc. (MYMD)](* - Despite Market Weakness, [MYMD]( continues to consolidate at support 👉BIVI up over 30% on promising Phase 2 Alzheimer’s Data 👉BPTS up over 25% after Promising Data From COVID-19 Treatment Study *This is an Issuer-Paid Advertisement, See Disclosure Below  Sponsored By 👉 [MyMD Pharmaceuticals, Inc. (MYMD)](* - Despite Market Weakness [MYMD]( continues to consolidate at support. The QQQ’s have closed lower than they opened on 6 out of the last 7 trading sessions. Despite this overall market weakness, [MYMD](is still holding above the $3.20 support level and still trading around the MAJOR $3.30 support area. Over the last couple of weeks [MYMD]( has been trading in a range approximately between $3.20 to $3.70. [Want To Know More About MYMD?]( Once again the stock is approaching the lower bound of this range, an important level to watch. Given the relative strength the stock has shown compared to the overall market, we would expect a bounce in the market to be positive for [MYMD](. Above the top of the range at $3.70 the next major levels of resistance are not until $4.50 and then $5. [Click Here To FInd Out More About the Company Working to Significantly Increase Lifespan](  *This is an Issuer-Paid Advertisement, See Disclosure Below  Experts Discuss options strategy LIVE! Today [LIVE at 2pm](, Jeff Bishop, Jeff Williams and Davis Martin will be in the [360 Wall St](Chat to talk about an exciting options trading strategy targeting very short-term trades on a specific ticker symbol each day at the market open. Here was the reaction to Jeff Williams trading SPY options LIVE in [360 Wall St]( yesterday from our members: Don’t miss Jeff in the[360 Wall st chatroom](, as he alerts his best trade ideas in real time! [Click here to jump in the 360 Wallstreet chat room](  BIVI up over 30% on promising Phase 2 Alzheimer’s Data BioVie (BIVI) announced that ‘Vast majority of patients saw significant improvements in the Global Rating of Change’ According to Finviz the stock has less than 1.5million of shares in the float. “Low floats” such as this can have some wild moves due to the ease with which big players can buy up most of the stock available. In August of last year BIVI was trading as high as $14. BIVI was trading in the $4.50’s in pre-market. Expect some possible fireworks here today. Don’t miss our expert traders in the[360 Wall st chatroom](, as they alerts their best trade ideas in real time!  BPTS up over 25% after Promising Data From COVID-19 Treatment Study  Biophytis SA (BPTS) released phase 2-3 results evaluating Sarceneos in treating COVID-19 related respiratory failure. In the results Sarconeos reduced by 39% the risk of respiratory failure or early death at 28 days compared to placebo.  The stock was up over 40% at one point in the pre-market after the news. BPTS was trading as high as $4.50 at the beginning of the year. Near term resistance levels are $1.50, $2 and then $3 here. [Here is your direct link to the 360 chat room](  To Your Success! 62 Calef Hwy #233 Lee, New Hampshire 03861 United States Questions or concerns about our products? Email [Support@360.com](  © Copyright 2022, RagingBull - Refund Policy - Privacy Policy - Terms & Conditions  *THIS IS AN ISSUER-PAID ADVERTISEMENT, SEE DISCLOSURE BELOW*ISSUER-PAID ADVERTISEMENT. MyMD, Inc. (“MYMD” or the “Company”) HAS PAID ORWILL PAY SHERWOOD VENTURES, LLC (“Sherwood”) TWENTY-THOUSAND DOLLARS USD PER MONTH FOR THREE MONTHS (THE “INITIAL TERM”) IN CASH, SHARES OF RESTRICTED COMMON STOCK WITH A VALUE OF ONE-HUNDRED-FIFTY THOUSAND DOLLARS, AND WARRANTS VALUED AT ISSUANCE OF SEVENTY-FIVE THOUSAND DOLLARS FOR MARKETING SERVICES INCLUDING COMMUNICATING TO THE PUBLIC ABOUT THE COMPANY THROUGH SHERWOOD’S AFFILIATE RAGINGBULL.COM, LLC (“RAGING BULL”), AMONG OTHERS. THIS ADVERTISEMENT IS PART OF THOSE ISSUER-PAID MARKETING SERVICES. FOR DETAILED COMPENSATION AND MORE INFORMATION, PLEASE SEE THE FULL DISCLOSURE LOCATED AT HTTPS://BOARDROOMINVESTING.COM/MYMD-DISCLAIMER. DISCLAIMER: To more fully understand any Ragingbull.com, LLC ("RagingBull") subscription, website, application or other service ("Services"), please review our full disclaimer located at [(. FOR EDUCATIONAL AND INFORMATION PURPOSES ONLY; NOT INVESTMENT ADVICE. Any RagingBull Service offered is for educational and informational purposes only and should NOT be construed as a securities-related offer or solicitation, or be relied upon as personalized investment advice. RagingBull strongly recommends you consult a licensed or registered professional before making any investment decision. RESULTS PRESENTED NOT TYPICAL OR VERIFIED. RagingBull Services may contain information regarding the historical trading performance of RagingBull owners or employees, and/or testimonials of non-employees depicting profitability that are believed to be true based on the representations of the persons voluntarily providing the testimonial. However, subscribers' trading results have NOT been tracked or verified and past performance is not necessarily indicative of future results, and the results presented in this communication are NOT TYPICAL. Actual results will vary widely given a variety of factors such as experience, skill, risk mitigation practices, market dynamics and the amount of capital deployed. Investing in securities is speculative and carries a high degree of risk; you may lose some, all, or possibly more than your original investment. RAGINGBULL IS NOT AN INVESTMENT ADVISOR OR REGISTERED BROKER. Neither RagingBull nor any of its owners or employees is registered as a securities broker-dealer, broker, investment advisor (IA), or IA representative with the U.S. Securities and Exchange Commission, any state securities regulatory authority, or any self-regulatory organization. Employees, owners, and other service providers of [RagingBull.com](, LLC are paid in whole or in part by commission based on their sales of Services to subscribers. WE MAY HOLD SECURITIES DISCUSSED. RagingBull has not been paid directly or indirectly by the issuer of any security mentioned in the Services except possibly by advertisers in this email. However, Ragingbull.com, LLC, its owners, and its employees may purchase, sell, or hold long or short positions in securities of the companies mentioned in this communication. [Manage your email subscriptions.](